000 | 01668 a2200481 4500 | ||
---|---|---|---|
005 | 20250515015014.0 | ||
264 | 0 | _c20060914 | |
008 | 200609s 0 0 eng d | ||
022 | _a0171-6425 | ||
024 | 7 |
_a10.1055/s-2005-872853 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGödje, O | |
245 | 0 | 0 |
_aCoagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. _h[electronic resource] |
260 |
_bThe Thoracic and cardiovascular surgeon _cFeb 2006 |
||
300 |
_a26-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCoronary Artery Bypass _xmethods |
650 | 0 | 4 |
_aCoronary Disease _xblood |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aExtracorporeal Circulation _xadverse effects |
650 | 0 | 4 |
_aFactor XIII _xadministration & dosage |
650 | 0 | 4 |
_aFibrinolysin _xtherapeutic use |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPostoperative Hemorrhage _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aGallmeier, U | |
700 | 1 | _aSchelian, M | |
700 | 1 | _aGrünewald, M | |
700 | 1 | _aMair, H | |
773 | 0 |
_tThe Thoracic and cardiovascular surgeon _gvol. 54 _gno. 1 _gp. 26-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2005-872853 _zAvailable from publisher's website |
999 |
_c16096730 _d16096730 |